Spruce Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -475%. Total operating expenses were $62,082,000.

Profit Margin

Spruce Biosciences, Inc. (NASDAQ:SPRB): Profit margin
2018 0 -9.85M
2019 0 -13.23M
2020 0 -30.02M
2021 0 -42.68M
2022 0 -45.07M
2023 10.08M -47.91M -474.96%

SPRB Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
10.08M00000
Cost of revenue
49.43M429K381K102K12K0
Gross profit
-39.34M-429K-381K-102K-12K0
Operating exp.
Research and development
49.43M35.19M30.69M23.85M10.81M8.40M
Selling and marketing
000000
Total operating expenses
62.08M47.28M42.06M29.41M13.10M9.97M
Operating income
-51.99M-47.28M-42.06M-29.41M-13.10M-9.97M
Other income (expenses), net
4.07M1.10M-226K-123K19K114K
Income before tax
-47.91M-46.18M-42.29M-29.53M-13.08M-9.85M
Income tax expense
0-1.10M396K487K149K114K
Net income
-47.91M-45.07M-42.68M-30.02M-13.23M-9.85M
Earnings per share
Basic EPS
-1.24-1.92-1.83-1.29-0.59-2.01
Diluted EPS
-1.24-1.92-1.83-1.29-0.59-2.01
Data sourceData sourceData sourceData source